{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-055142","form_type":"8-K","ticker":"DOMH","cik":"0000012239","company_name":"Dominari Holdings Inc.","filed_at":"2022-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.165914+00:00","generated_at":"2026-06-23T10:46:55.386116+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"AIkido Pharma subsidiary Dominari Financial to acquire broker-dealer Fieldpoint Private Securities for $2M","bullets":["Purchase price $2,000,001 for 100% membership interests of FINRA-registered broker-dealer Fieldpoint Private Securities.","Two-stage closing: $2M for 20% now, then $1 for remaining 80% upon FINRA Rule 1017 approval.","Acquisition aims to diversify AIkido beyond biotech into financial services; Dominari Financial launched June 2022.","Press release: board supports roll-up strategy targeting ultra-high-net-worth wealth management firms.","If FINRA denies the Rule 1017 application, seller must pay $2M to Dominari and revert the initial 20% membership interests."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-055142","json":"https://secwatch.observer/filing/0001213900-22-055142.json","markdown":"https://secwatch.observer/filing/0001213900-22-055142.md","text":"https://secwatch.observer/filing/0001213900-22-055142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12239/000121390022055142/0001213900-22-055142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12239/000121390022055142/ea165577-8k_aikidopharm.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T10:46:55.386116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}